APA (7th ed.) Citation

Ozkan, A., Eskiler, G., Kazan, N., & Turna, O. (2023). Histone deacetylase inhibitor sodium butyrate regulates the activation of toll-like receptor 4/interferon regulatory factor-3 signaling pathways in prostate cancer cells. Journal of Cancer Research & Therapeutics, 19(7), 1812. https://doi.org/10.4103/jcrt.jcrt_2032_21

Chicago Style (17th ed.) Citation

Ozkan, Asuman, Gamze Eskiler, Nur Kazan, and Ozge Turna. "Histone Deacetylase Inhibitor Sodium Butyrate Regulates the Activation of Toll-like Receptor 4/interferon Regulatory Factor-3 Signaling Pathways in Prostate Cancer Cells." Journal of Cancer Research & Therapeutics 19, no. 7 (2023): 1812. https://doi.org/10.4103/jcrt.jcrt_2032_21.

MLA (9th ed.) Citation

Ozkan, Asuman, et al. "Histone Deacetylase Inhibitor Sodium Butyrate Regulates the Activation of Toll-like Receptor 4/interferon Regulatory Factor-3 Signaling Pathways in Prostate Cancer Cells." Journal of Cancer Research & Therapeutics, vol. 19, no. 7, 2023, p. 1812, https://doi.org/10.4103/jcrt.jcrt_2032_21.